The Assessment of Perceived Stress, Anxiety, Depression, Insomnia, Sleep Quality, and Drug Adherence in Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic
Open Access
- 29 April 2025
- journal article
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 12 (2) , 1-7
Abstract
Anxiety–depression,COVID-19 pandemic,drug adherence,insomnia–sleep quality,perceived stress,systemic lupus erythematosusKeywords
This publication has 26 references indexed in Scilit:
- Older Peoples’ Adherence and Awareness of Changes in Drug Therapy after Discharge from HospitalPharmacy, 2018
- Quality of life in systemic lupus erythematosus and its measurementRheumatology, 2018
- A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response ModifiersClinical Therapeutics, 2016
- Sleep disorders and systemic lupus erythematosusLupus, 2014
- Adherence to treatment in systemic lupus erythematosus patientsBest Practice & Research Clinical Rheumatology, 2013
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals of the Rheumatic Diseases, 2010
- Validation of the Insomnia Severity Index as an outcome measure for insomnia researchSleep Medicine, 2001
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989
- A Global Measure of Perceived StressJournal of Health and Social Behavior, 1983
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983